The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Introduction: Methods, Commentary, and Summary
Abstract
OBJECTIVES: Due to inherent dangers and barriers to research in emergency settings, few data are available to guide clinicians about how best to manage behavioral emergencies. Key constructs such as agitation are poorly defined. This lack of empirical data led us to undertake a survey of expert opinion, results of which were published in the 2001 Expert Consensus Guidelines on the Treatment of Behavioral Emergencies. Several second-generation (atypical) antipsychotics (SGAs) are now available in new formulations for treating behavioral emergencies (e.g., intramuscular [i.m.] olanzapine and ziprasidone; rapidly dissolving tablets of olanzapine and risperidone). Critical questions face the field. The SGAs are significantly different from the FGAs and from each other and have not been studied in unselected patients as were the FGAs. Can the SGAs can be thought of as a class, do all antipsychotics have similar anti-agitation effects in different conditions, and, if equally effective, what limits might their safety profiles impose? Should antipsychotics be used more specifically to treat psychotic conditions, while benzodiazepines (BNZs) alone are used nonspecifically? Few data are available concerning combinations of SGAs and BNZs, and findings concerning the traditional combination of haloperidol plus a BNZ may not be relevant to combinations with SGAs. The culture is also evolving with more emphasis on patient involvement in treatment decisions. An international consensus has been developing that calming rather than sedation is the appropriate endpoint of behavioral emergency interventions. We undertook a new survey of expert opinion to update recommendations from the earlier survey. METHOD: A written survey of 61 questions (1,020 options) was mailed to 50 experts in the field, 48 (96%) of whom completed it. The survey sought to define level of agitation at which emergency interventions are appropriate, scope of assessment depending on urgency and patients' ability to cooperate, guiding principles for selecting interventions, and appropriate physical and medication strategies at different levels of diagnostic confidence for a variety of provisional diagnoses and complicating conditions. A modified version of the RAND Corporation's 9-point scale for rating appropriateness of medical decisions was used to score most options. Consensus was defined as a non-random distribution of scores by chi-square "goodness-of-fit" test. We assigned a categorical rank (first line/preferred, second line/alternate, third line/usually inappropriate) to each option based on the 95% confidence interval around the mean. Ratings were used to develop guidelines for preferred strategies in key clinical situations. This study received financial support from multiple sponsors, with the panel kept blind to sponsorship to reduce possible bias. Medication ratings were based on responses of only those respondents with direct experience with each drug. In reporting practice patterns, the panel was asked to respond based on actual data rather than estimates. RESULTS: The expert panel reached consensus on 78% of the options rated on the 9-point scale. The responses suggest that physicians can make provisional diagnoses with some confidence and that pharmacological and nonpharmacological interventions are selected differentially based on diagnosis and other salient demographic and medical features. BNZs are recommended when no data are available, when there is no specific treatment (e.g., personality disorder), or when they may have specific benefits (e.g., intoxication). No single SGA emerges as a nonspecific replacement for haloperidol; instead, different SGAs are preferred in various circumstances consistent with current evidence. To the degree that haloperidol is recommended, it is almost always in combination with a BNZ; haloperidol alone is preferred only in the medically compromised. In contrast, the SGAs are more often recommended for use alone, and the panel would avoid combining BNZs with some SGAs. Oral risperidone alone or combined with a BNZ receives strong support in a variety of situations. Oral olanzapine was rated very similarly to risperidone, with slightly higher ratings than risperidone in situations where it has been studied (e.g., schizophrenia, mania) and slightly lower ratings where it has not been studied or safety may be a concern; there was less support for combining oral olanzapine with a BNZ. For oral treatment of agitation related to schizophrenia or mania, olanzapine alone, risperidone alone or combined with a BNZ, and haloperidol plus a BNZ are first line, with strong support also for combining divalproex with the antipsychotic for presumed mania. Oral ziprasidone and quetiapine generally received similar second-line ratings in most situations. If a parenteral agent is needed, i.m. olanzapine alone received somewhat more support than i.m. ziprasidone alone; however, there was more support for i.m. ziprasidone alon
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Clarifying Confusion: The Confusion Assessment Method: A New Method for Detection of Delirium
Inouye, S. K., van Dyck, C. H., Alessi, C. A., Balkin, S., Siegal, A. P., & Horwitz, R. I. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-12-941 · Cited by 5,250
Discovering the Neural Basis of Human Social Anxiety: A Diagnostic and Therapeutic Imperative
Charney, D. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.1 · Cited by 1,428
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
Davis, J. M., Chen, N., & Glick, I. D. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.553 · Cited by 1,034
A Method for the Detailed Assessment of the Appropriateness of Medical Technologies
Brook, R. H., Chassin, M. R., Fink, A., Solomon, D. H., Kosecoff, J., & Park, R. E. (1986) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300002774 · Cited by 762
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.2.231 · Cited by 617
Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of Psychoses
Baldessarini, R. J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800250095013 · Cited by 545
Olanzapine vs haloperidol: treating delirium in a critical care setting
Skrobik, Y. K., Bergeron, N., Dumont, M., & Gottfried, S. B. (2004) · Intensive Care Medicine · doi:10.1007/s00134-003-2117-0 · Cited by 455
Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.5.592 · Cited by 434
Research works printed but not linked: 31
- Djulbegovic, 1998, Oncology, 12, 310
- Kahn, 1996, J Clin Psychiatry, 57, 1
- McEvoy, 1996, J Clin Psychiatry, 57, 1
- March, 1997, J Clin Psychiatry, 58, 1
- McEvoy, 1999, J Clin Psychiatry, 60, 1
- Foa, 1999, J Clin Psychiatry, 60, 1
- Rush, 2000, AJMR, 105, 159
- Conners, 2001, J Atten Disord, 4, S1
- Kane, 2003, J Clin Psychiatry, 64, 1
- Alexopoulos, 2004, J Clin Psychiatry, 65, 1
- Kahn, 1997, Psychopharmacol Bull, 33, 631
- Copersino, 2003, Psychiatr Serv, 54, 314, 10.1176/appi.ps.54.3.314 · doi:10.1176/appi.ps.54.3.314
- Martel, 2003, Acad Emerg Med, 10, 510, 10.1197/aemj.10.5.510-b · doi:10.1197/aemj.10.5.510-b
- Currier, 2000, J Clin Psychiatry, 61, 21
- Salzman, 1991, J Clin Psychiatry, 52, 177
- Currier, 2001, J Clin Psychiatry, 62, 153, 10.4088/JCP.v62n0303 · doi:10.4088/jcp.v62n0303
- Daniel, 2004, Int Clin Psychopharmacol, 19, 9, 10.1097/00004850-200401000-00002 · doi:10.1097/00004850-200401000-00002
- Reschke, 1974, Dis Nerv Sys, 35, 112
- Hatta, 2002, Psychiatr Serv, 53, 1077, 10.1176/appi.ps.53.9.1077 · doi:10.1176/appi.ps.53.9.1077
- Bourdinaud, 2003, Encephale, 29, 89
- Stotsky, 1977, yst, 38, 967
- Binder, 1981, J Clin Psychiatry, 42, 203
- Paprocki, 1977, Curr Ther Res Clin Exp, 21, 80
- Tuason, 1986, J Clin Psychiatry, 47, 126
- Gerstenzang, 1977, Dis Nerv Syst, 38, 581
- Brook, 2000, J Clin Psychiatry, 61, 933, 10.4088/JCP.v61n1208 · doi:10.4088/jcp.v61n1208
- Preval, 2005, Gen Hosp Psychiatry, 27, 140, 10.1016/j.genhosppsych.2004.11.004 · doi:10.1016/j.genhosppsych.2004.11.004
- Scahill, 2005, J Psychopharmacol, 19, 205, 10.1177/0269881105049042 · doi:10.1177/0269881105049042
- Wyant, 1990, Psychopharmacol Bull, 26, 126
- Chouinard, 1993, Can J Psychiatry, 38, S114
- Salzman, 1988, J Clin Psychiatry, 49, 13
Cited by
Assessment and management of agitation in psychiatry: Expert consensus
Garriga, M., Pacchiarotti, I., Kasper, S., Zeller, S. L., Allen, M. H., Vázquez, G., Baldaçara, L., San, L., McAllister-Williams, R. H., Fountoulakis, K. N., et al. (2016) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1132007 · Cited by 309
Self-citationTreatment of pediatric epilepsy: European expert opinion, 2007
Wheless, J. W., Clarke, D. F., Arzimanoglou, A., & Carpenter, D. (2007) · Epileptic Disorders · doi:10.1684/epd.2007.0144 · Cited by 295
Self-citationHays, H., Jolliff, H., & Casavant, M. (2012) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2012.7.12527 · Cited by 271
Llorca, P. M., Abbar, M., Courtet, P., Guillaume, S., Lancrenon, S., & Samalin, L. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-340 · Cited by 188
“This method is very close to the Expert Consensus Guidelines methodology and has been applied to a variety of psychiatric disorders [4,21-27].”
MethodRosen, T., Connors, S., Clark, S., Halpern, A., Stern, M. E., DeWald, J., Lachs, M. S., & Flomenbaum, N. (2015) · Advanced Emergency Nursing Journal · doi:10.1097/tme.0000000000000066 · Cited by 49
Metadata
- Authors
- ALLEN, M. H., CURRIER, G. W., CARPENTER, D., ROSS, R. W., & DOCHERTY, J. P.
- Venue
- Journal of Psychiatric Practice
- Published
- 2005-11
- Volume
- 11
- Pages
- 5-25
- ISSN
- 1527-4160 (ISSN-L)
- 1538-1145
- OpenAlex
- W2086011500
- Cited by
- 267
- References
- 75
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Introduction: Methods, Commentary, and Summary. https://app.cochat.ai/papers/10.1097/00131746-200511001-00002
- The paper
- ALLEN, M. H., CURRIER, G. W., CARPENTER, D., ROSS, R. W., & DOCHERTY, J. P. (2005). Introduction: Methods, Commentary, and Summary. Journal of Psychiatric Practice. https://doi.org/10.1097/00131746-200511001-00002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.